Ticker: ELYM

Company: Eliem Therapeutics, Inc.

Person: RA CAPITAL MANAGEMENT, LP, director, owns ten percent - or more - of the company

Transaction date: Jan. 5, 2026

Reporting date: Jan. 7, 2026

Average share price: 3.5

Bought 7111.0 shares for 24888.5